Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
S&P Biotech SPDR (XBI)
S&P Biotech SPDR (XBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
Trade XBI with:
  • Price/Earnings ttm 17.88
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.040 on 03/22/21
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 26.31% ( -0.09%)
  • Historical Volatility 26.87%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 57.82% on 06/13/22
  • IV Low 26.31% on 06/09/23
  • Put/Call Vol Ratio 1.46
  • Today's Volume 80,524
  • Volume Avg (30-Day) 55,659
  • Put/Call OI Ratio 1.03
  • Today's Open Interest 825,269
  • Open Int (30-Day) 824,187

Price Performance

See More
Period Period Low Period High Performance
1-Month
82.61 +6.11%
on 05/25/23
89.82 -2.41%
on 05/23/23
+1.75 (+2.04%)
since 05/09/23
3-Month
72.44 +21.01%
on 03/24/23
89.82 -2.41%
on 05/23/23
+8.93 (+11.34%)
since 03/09/23
52-Week
62.13 +41.09%
on 06/14/22
95.18 -7.90%
on 08/11/22
+17.40 (+24.77%)
since 06/09/22

Most Recent Stories

More News
Why These 3 Nasdaq Stocks Buckled Today

The FTC's decision to sue to block a high-profile merger is weighing on biotech valuations today.

XBI : 87.66 (-0.52%)
APLS : 90.01 (-0.18%)
MDGL : 265.53 (-1.36%)
SRPT : 127.67 (+1.40%)
AMGN : 218.76 (-0.91%)
HZNP : 99.25 (-0.17%)
Biotech ETFs Pop on M&A Resurgence

2023 could be a year of heightened biotech dealmaking activity

GSK : 34.76 (+0.12%)
NVS : 100.93 (+0.28%)
PFE : 38.97 (-0.31%)
MRK : 110.71 (+0.35%)
AMGN : 218.76 (-0.91%)
GILD : 78.12 (-0.36%)
VRTX : 334.11 (+0.46%)
IBB : 128.84 (-0.15%)
SGEN : 196.60 (+0.97%)
RXDX : 198.99 (+0.01%)
XBI : 87.66 (-0.52%)
SBIO : 32.88 (-0.40%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 62.40 (-0.82%)
REGN : 746.52 (-0.48%)
AMGN : 218.76 (-0.91%)
VRTX : 334.11 (+0.46%)
IBB : 128.84 (-0.15%)
XBI : 87.66 (-0.52%)
Time to Spring-Clean...Your Stock Portfolio

Plus, Howard Marks, co-founder of Oaktree Capital Management, joins the podcast to discuss topics including China's effect on inflation in the U.S.

BRK.AX : 0.013 (-13.33%)
UAA : 7.43 (-1.20%)
MA : 369.22 (+0.44%)
V : 223.56 (+0.23%)
DG : 153.05 (-1.80%)
SQ : 64.94 (-0.23%)
UA : 6.85 (-0.87%)
ZG : 44.14 (-3.52%)
COST : 517.28 (-0.54%)
GOOGL : 122.23 (+0.07%)
AAPL : 180.96 (+0.22%)
CDNS : 229.30 (+0.53%)
Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Smart Beta ETF report for PBE

PBE : 62.40 (-0.82%)
BMRN : 91.37 (-0.96%)
GILD : 78.12 (-0.36%)
INCY : 61.04 (-0.76%)
IBB : 128.84 (-0.15%)
XBI : 87.66 (-0.52%)
This Blue Chip Dividend Stock Should Return to Form When the Risk Premium Flips

T-bills may be the flavor of the month, but history has shown this top biotech stock is a far better long-term investment.

HZNP : 99.25 (-0.17%)
IEF : 96.94 (-0.36%)
XBI : 87.66 (-0.52%)
AMGN : 218.76 (-0.91%)
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

Smart Beta ETF report for XBI

XBI : 87.66 (-0.52%)
BIIB : 308.88 (+1.31%)
HALO : 33.96 (-0.59%)
IBB : 128.84 (-0.15%)
HZNP : 99.25 (-0.17%)
FBT : 157.07 (-0.44%)
Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

BBH : 157.94 (-0.13%)
AMGN : 218.76 (-0.91%)
GILD : 78.12 (-0.36%)
VRTX : 334.11 (+0.46%)
IBB : 128.84 (-0.15%)
XBI : 87.66 (-0.52%)
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Sector ETF report for FBT

FBT : 157.07 (-0.44%)
MRNA : 123.26 (-1.34%)
IBB : 128.84 (-0.15%)
GRFS : 8.83 (+0.34%)
EXAS : 87.81 (-3.13%)
XBI : 87.66 (-0.52%)
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Smart Beta ETF report for IBB

IBB : 128.84 (-0.15%)
REGN : 746.52 (-0.48%)
AMGN : 218.76 (-0.91%)
GILD : 78.12 (-0.36%)
XBI : 87.66 (-0.52%)
FBT : 157.07 (-0.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Key Turning Points

3rd Resistance Point 90.21
2nd Resistance Point 89.52
1st Resistance Point 88.59
Last Price 87.66
1st Support Level 86.97
2nd Support Level 86.28
3rd Support Level 85.35

See More

52-Week High 95.18
Last Price 87.66
Fibonacci 61.8% 82.55
Fibonacci 50% 78.65
Fibonacci 38.2% 74.75
52-Week Low 62.13

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar